These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 25741000)

  • 1. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
    Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
    Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
    J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703.
    Matthews PC; Adland E; Listgarten J; Leslie A; Mkhwanazi N; Carlson JM; Harndahl M; Stryhn A; Payne RP; Ogwu A; Huang KH; Frater J; Paioni P; Kloverpris H; Jooste P; Goedhals D; van Vuuren C; Steyn D; Riddell L; Chen F; Luzzi G; Balachandran T; Ndung'u T; Buus S; Carrington M; Shapiro R; Heckerman D; Goulder PJ
    J Immunol; 2011 May; 186(10):5675-86. PubMed ID: 21498667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of HLA-B*5401-restricted HIV-1-Nef and Pol-specific CTL epitopes.
    Kitano M; Kobayashi N; Kawashima Y; Akahoshi T; Nokihara K; Oka S; Takighuchi M
    Microbes Infect; 2008 Jun; 10(7):764-72. PubMed ID: 18538615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E.
    Chikata T; Tran GV; Murakoshi H; Akahoshi T; Qi Y; Naranbhai V; Kuse N; Tamura Y; Koyanagi M; Sakai S; Nguyen DH; Nguyen DT; Nguyen HT; Nguyen TV; Oka S; Martin MP; Carrington M; Sakai K; Nguyen KV; Takiguchi M
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
    Zhang Y; Chikata T; Kuse N; Murakoshi H; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2022 Nov; 96(22):e0124822. PubMed ID: 36326273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of HIV-1 Replication by CD8
    Nguyen HT; Kuse N; Zhang Y; Murakoshi H; Maeda Y; Tamura Y; Maruyama R; Tran GV; Nguyen TV; Nguyen KV; Oka S; Chikata T; Takiguchi M
    J Virol; 2022 Oct; 96(19):e0081122. PubMed ID: 36154612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective Haplotype.
    Chikata T; Murakoshi H; Koyanagi M; Honda K; Gatanaga H; Oka S; Takiguchi M
    J Infect Dis; 2017 Dec; 216(11):1415-1424. PubMed ID: 28968792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of TI8-8V mutant associated with long-term control of HIV-1 by cross-reactive HLA-B*51:01-restricted cytotoxic T cells.
    Kuse N; Akahoshi T; Gatanaga H; Ueno T; Oka S; Takiguchi M
    J Immunol; 2014 Nov; 193(10):4814-22. PubMed ID: 25305317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of 2 HIV-1 Gag immunodominant epitopes restricted by Asian HLA allele HLA-B*4801.
    Murakoshi H; Kitano M; Akahoshi T; Kawashima Y; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2009 Mar; 70(3):170-4. PubMed ID: 19167445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.